Clinical Trial Update: The Use of Levonorgestrel-Releasing Device (Metraplant-E) in the Treatment of Dysfunctional Uterine Bleeding [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 study assesses the safety and preliminary efficacy of the levonorgestrel-releasing Metraplant-E intrauterine device for treating dys…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysfunctional Uterine Bleeding

Drugs mentioned

• Metraplant-E (levonorgestrel-releasing intrauterine system)

Snippet

Sponsor: Ain Shams Maternity Hospital | Conditions: Dysfunctional Uterine Bleeding | Phase 1, Phase 2 | Status: COMPLETED